<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1405-888X</journal-id>
<journal-title><![CDATA[TIP. Revista especializada en ciencias químico-biológicas]]></journal-title>
<abbrev-journal-title><![CDATA[TIP]]></abbrev-journal-title>
<issn>1405-888X</issn>
<publisher>
<publisher-name><![CDATA[Universidad Nacional Autónoma de México, Facultad de Estudios Superiores Zaragoza]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1405-888X2016000100024</article-id>
<article-id pub-id-type="doi">10.1016/j.recqb.2016.02.003</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Neuroinflamación y epilepsia]]></article-title>
<article-title xml:lang="en"><![CDATA[Epilepsy and neuroinflammation]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Herrera-Vázquez]]></surname>
<given-names><![CDATA[Omar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Toledo Rojas]]></surname>
<given-names><![CDATA[Andrea]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fleury]]></surname>
<given-names><![CDATA[Agnès]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Nacional Autónoma de México Facultad de Medicina Instituto de Investigaciones Biomédicas]]></institution>
<addr-line><![CDATA[México D.F]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2016</year>
</pub-date>
<volume>19</volume>
<numero>1</numero>
<fpage>24</fpage>
<lpage>31</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1405-888X2016000100024&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1405-888X2016000100024&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1405-888X2016000100024&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen La epilepsia es un trastorno neurológico que afecta a 50 millones de personas en el mundo. Se define por la presencia de crisis epilépticas espontáneas resultado de descargas sincrónicas de una población neuronal debido a un dinamismo anormal de las redes neuronales. Diferentes factores han sido implicados en su etiopatogenia, uno de ellos siendo los procesos inmunológicos e inflamatorios. En el presente trabajo revisaremos los datos existentes sobre el papel de la inflamación/neuroinflamación en la epilepsia.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Epilepsy is a neurological disorder affecting 50 million people worldwide. It is defined by the presence of spontaneous seizures result of synchronous discharges of neuronal population due to abnormal dynamics of neural networks. Different factors have been implicated in its pathogenesis, one of them being immune and inflammatory processes. In this paper we review the existing data on the role of inflammation / neuroinflammation in epilepsy.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[epilepsia]]></kwd>
<kwd lng="es"><![CDATA[inflamación]]></kwd>
<kwd lng="es"><![CDATA[neuroinflamación]]></kwd>
<kwd lng="en"><![CDATA[epilepsy]]></kwd>
<kwd lng="en"><![CDATA[inflammation]]></kwd>
<kwd lng="en"><![CDATA[neuroinflammation]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The descriptive epidemiology of epilepsy-a review]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Banerjee]]></surname>
<given-names><![CDATA[P.N.]]></given-names>
</name>
<name>
<surname><![CDATA[Filippi]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Allen Hauser]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsy Res]]></source>
<year>2009</year>
<volume>85</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>31-45</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kwan]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsia]]></source>
<year>2010</year>
<volume>51</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1069-77</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Pharmacoresistance and the role of surgery in difficult to treat epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wiebe]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Jette]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nat. Rev. Neurol]]></source>
<year>2012</year>
<volume>8</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>669-77</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Early Identification of Refractory Epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kwan]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Brodie]]></surname>
<given-names><![CDATA[M.J.]]></given-names>
</name>
</person-group>
<source><![CDATA[N. Engl. J. Med.]]></source>
<year>2000</year>
<volume>342</volume>
<page-range>314-9</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Neuropathology of temporal lobe epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Al Sufiani]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Ang]]></surname>
<given-names><![CDATA[L.C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsy Res. Treat.]]></source>
<year>2012</year>
<volume>2012</volume>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The pivotal role of immunity and inflammatory processes in epilepsy is increasingly recognized: introduction]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vezzani]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Rüegg]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsia.]]></source>
<year>2011</year>
<volume>52</volume>
<page-range>1-4</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The role of inflammation in epileptogenesis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vezzani]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Friedman]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Dingledine]]></surname>
<given-names><![CDATA[R.J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuropharmacology]]></source>
<year>2013</year>
<volume>69</volume>
<page-range>16-24</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Inflammatory pathways of seizure disorders]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marchi]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Granata]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Janigro]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Trends Neurosci.]]></source>
<year>2014</year>
<volume>37</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>55-65</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Some cross-talks between immune cells and epilepsy should not be forgotten]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Tang]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neurol. Sci.]]></source>
<year>2014</year>
<volume>35</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1843-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Focal seizures due to chronic localized encephalitis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rasmussen]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Olszewski]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Lloydsmith]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neurology]]></source>
<year>1958</year>
<volume>8</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>435-45</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Alpha7 acetylcholine receptor antibodies in two patients with Rasmussen encephalitis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Watson]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neurology]]></source>
<year>2005</year>
<volume>65</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1802-4</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Autoantibodies to Munc18, cerebral plasmacells and B-lymphocytes in Rasmussen encephalitis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez-Barón]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Bien]]></surname>
<given-names><![CDATA[C.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Schramm]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Elger]]></surname>
<given-names><![CDATA[C.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Becker]]></surname>
<given-names><![CDATA[A.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Schoch]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsy Res.]]></source>
<year>2008</year>
<volume>80</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>93-7</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Immune-mediated epilepsies]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Granata]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Cross]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Theodore]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Avanzini]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsia.]]></source>
<year>2011</year>
<volume>52</volume>
<numero>^s3</numero>
<issue>^s3</issue>
<supplement>3</supplement>
<page-range>5-11</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Autoantibodies associated with diseases of the CNS: new developments and future challenges]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vincent]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Bien]]></surname>
<given-names><![CDATA[C.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Irani]]></surname>
<given-names><![CDATA[S.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Waters]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet Neurol]]></source>
<year>2011</year>
<volume>10</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>759-72</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Autoimmune epilepsy: clinical characteristics and response to immunotherapy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quek]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch. Neurol.]]></source>
<year>2012</year>
<volume>69</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>582-93</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bien]]></surname>
<given-names><![CDATA[C.G.]]></given-names>
</name>
</person-group>
<source><![CDATA[Brain]]></source>
<year>2012</year>
<volume>135</volume>
<page-range>1622-38</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Varadkar]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet Neurol.]]></source>
<year>2014</year>
<volume>13</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>195-205</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Generalized epilepsies: immunologic and inflammatory mechanisms. Semin. Pediatr]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[K.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Walleigh]]></surname>
<given-names><![CDATA[D.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Legido]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neurol.]]></source>
<year>2014</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>214-20</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Autoimmune epilepsies]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bien]]></surname>
<given-names><![CDATA[C.G.]]></given-names>
</name>
<name>
<surname><![CDATA[Bauer]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neurotherapeutics.]]></source>
<year>2014</year>
<volume>11</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>311-8</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Systemic and neurologic autoimmune disorders associated with seizures or epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vincent]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Crino]]></surname>
<given-names><![CDATA[P.B.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsia]]></source>
<year>2011</year>
<volume>52</volume>
<numero>^s3</numero>
<issue>^s3</issue>
<supplement>3</supplement>
<page-range>12-7</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Status epilepticus induces time-dependent neuronal and astrocytic expression of Interleukin-1 receptor type I in the rat limbic system]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ravizza]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Vezzani]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuroscience]]></source>
<year>2006</year>
<volume>137</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>301-8</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Gene Expression Profile in Temporal Lobe Epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aronica]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Gorter]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[The Neuroscientist: a Review Journal Bringing Neurobiology, Neurology and Psychiatry]]></source>
<year>2007</year>
<volume>13</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>100-8</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ravizza]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Gagliardi]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Noé]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Boer]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Aronica]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Vezzani]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neurobiology of Disease]]></source>
<year>2008</year>
<volume>29</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>142-60</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cellular injury and neuroinflammation in children with chronic intractable epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Choi]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[J. Neuroinflammation]]></source>
<year>2009</year>
<volume>6</volume>
<page-range>38</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boer]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<source><![CDATA[Brain Pathol.]]></source>
<year>2010</year>
<volume>20</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>704-19</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lyer]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsia]]></source>
<year>2010</year>
<volume>51</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1763-73</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lyer]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuroscience]]></source>
<year>2010</year>
<volume>167</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>929-45</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zattoni]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[J. Neurosci.]]></source>
<year>2011</year>
<volume>31</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>4037-50</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[TLR4 ATF-3 and IL8 inflammation mediator expression correlates with seizure frequency in human epileptic brain tissue]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pernhorst]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<source><![CDATA[Seizure]]></source>
<year>2013</year>
<volume>22</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>675-8</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Visualising Microglial Activation in Vivo]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Banati]]></surname>
<given-names><![CDATA[R.B.]]></given-names>
</name>
</person-group>
<source><![CDATA[Glia]]></source>
<year>2002</year>
<volume>40</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>206-17</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epilepsy surgery in a case of encephalitis: use of 11C-PK11195 positron emission tomography]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Chugani]]></surname>
<given-names><![CDATA[H.T.]]></given-names>
</name>
<name>
<surname><![CDATA[Luat]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Asano]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Sood]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Pediatr. Neurol.]]></source>
<year>2008</year>
<volume>38</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>439-42</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Butler]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<source><![CDATA[J. Neuroimaging]]></source>
<year>2013</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>129-31</page-range></nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rogers]]></surname>
<given-names><![CDATA[S.W.]]></given-names>
</name>
</person-group>
<source><![CDATA[Science.]]></source>
<year>1994</year>
<volume>265</volume>
<page-range>648-51</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Landau&#8211;Kleffner syndrome is not an eponymic badge of ignorance]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hirsch]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsy research]]></source>
<year>2006</year>
<volume>70</volume>
<page-range>239-47</page-range></nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chattopadhyay]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Hum. Mol. Genet.]]></source>
<year>2002</year>
<volume>11</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1421-31</page-range></nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Simoni]]></surname>
<given-names><![CDATA[M.G.]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur. J. Neurosci.]]></source>
<year>2000</year>
<volume>12</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>2623-33</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Glia and epilepsy: excitability and inflammation]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Devinsky]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
<name>
<surname><![CDATA[Vezzani]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Najjar]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[De Lanerolle]]></surname>
<given-names><![CDATA[N.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Rogawski]]></surname>
<given-names><![CDATA[M.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Trends Neurosci.]]></source>
<year>2013</year>
<volume>36</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>174-84</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maroso]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Balosso]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Ravizza]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Bianchi]]></surname>
<given-names><![CDATA[M.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Vezzani]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[J. Intern. Med.]]></source>
<year>2011</year>
<volume>270</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>319-26</page-range></nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Interleukin-1&#946; biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maroso]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neurotherapeutics]]></source>
<year>2011</year>
<volume>8</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>304-15</page-range></nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The IL-1beta system in epilepsy-associated malformations of cortical development]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ravizza]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neurobiol. Dis]]></source>
<year>2006</year>
<volume>24</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>128-43</page-range></nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vezzani]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Proc. Natl. Acad. Sci. U S A]]></source>
<year>2000</year>
<volume>97</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>11534-9</page-range></nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vezzani]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Balosso]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Maroso]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Zardoni]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Noé]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Ravizza]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<source><![CDATA[Curr. Opin. Investig. Drugs]]></source>
<year>2010</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>43-50</page-range></nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Status epilepticus, blood-brain barrier disruption, inflammation, and epileptogenesis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gorter]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
<name>
<surname><![CDATA[van Vliet]]></surname>
<given-names><![CDATA[E.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Aronica]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsy Behav.]]></source>
<year>2015</year>
<volume>49</volume>
<page-range>13-6</page-range></nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Blood-brain barrier dysfunction, seizures and epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[VanVliet]]></surname>
<given-names><![CDATA[E.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Aronica]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Gorter]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Semin. Cell. Dev. Biol.]]></source>
<year>2015</year>
<volume>38</volume>
<page-range>26-34</page-range></nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Adhesion molecule expression on murine cerebral endothelium following the injection of a proinflammagen or during acute neuronal degeneration]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bell]]></surname>
<given-names><![CDATA[M.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Perry]]></surname>
<given-names><![CDATA[V.H.]]></given-names>
</name>
</person-group>
<source><![CDATA[J. Neurocytol.]]></source>
<year>1995</year>
<volume>24</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>695-710</page-range></nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Expression of adhesion factors induced by epileptiform activity in the endothelium of the isolated guinea pig brain in vitro]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Librizzi]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Regondi]]></surname>
<given-names><![CDATA[M.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Pastori]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Frigerio]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Frassoni]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[de Curtis]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsia]]></source>
<year>2007</year>
<volume>48</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>743-51</page-range></nlm-citation>
</ref>
<ref id="B47">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[A role for leukocyte-endothelial adhesion mechanisms in epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fabene]]></surname>
<given-names><![CDATA[P.F.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nat. Med.]]></source>
<year>2008</year>
<volume>14</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1377-83</page-range></nlm-citation>
</ref>
<ref id="B48">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Inflammation in epilepsy: clinical observations]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aronica]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Crino]]></surname>
<given-names><![CDATA[P.B.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsia]]></source>
<year>2011</year>
<volume>52</volume>
<numero>^s3</numero>
<issue>^s3</issue>
<supplement>3</supplement>
<page-range>26-32</page-range></nlm-citation>
</ref>
<ref id="B49">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Role of nitric oxide in the enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Balter-Seri]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Yuhas]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Weizman]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Nofech-Mozes]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Kaminsky]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Ashkenazi]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Infect. Immun.]]></source>
<year>1999</year>
<volume>67</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>6364-8</page-range></nlm-citation>
</ref>
<ref id="B50">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The bacterial endotoxin lipopolysaccharide enhances seizure susceptibility in mice: involvement of proinflammatory factors: nitric oxide and prostaglandins]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sayyah]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Javad-Pour]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ghazi-Khansari]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuroscience.]]></source>
<year>2003</year>
<volume>122</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1073-80</page-range></nlm-citation>
</ref>
<ref id="B51">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Involvement of prostaglandins in an animal model of Shigella-related seizures]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yuhas]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Weizman]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Vanichkin]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Ashkenazi]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[J. Neuroimmunol.]]></source>
<year>2005</year>
<volume>168</volume>
<numero>1-2</numero>
<issue>1-2</issue>
<page-range>34-9</page-range></nlm-citation>
</ref>
<ref id="B52">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Peripheral inflammation increases seizure susceptibility via the induction of neuroinflammation and oxidative stress in the hippocampus]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ho]]></surname>
<given-names><![CDATA[Y.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[Y.T.]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[C.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Chao]]></surname>
<given-names><![CDATA[Y.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[A.Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Chan]]></surname>
<given-names><![CDATA[J.Y.]]></given-names>
</name>
</person-group>
<source><![CDATA[J. Biomed. Sci.]]></source>
<year>2015</year>
<volume>24</volume>
<page-range>22-46</page-range></nlm-citation>
</ref>
<ref id="B53">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Microglial activation and TNF alpha production mediate altered CNS excitability following peripheral inflammation]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Riazi]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Galic]]></surname>
<given-names><![CDATA[M.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Kuzmiski]]></surname>
<given-names><![CDATA[J.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Ho]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Sharkey]]></surname>
<given-names><![CDATA[K.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Pittman]]></surname>
<given-names><![CDATA[Q.J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Proc Natl Acad Sci U S A]]></source>
<year>2008</year>
<volume>105</volume>
<numero>44</numero>
<issue>44</issue>
<page-range>17151-6</page-range></nlm-citation>
</ref>
<ref id="B54">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Interictal alterations of cytokines and leukocytes in patients with active epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nowak]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Brain Behav. Immun.]]></source>
<year>2011</year>
<volume>25</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>423-8</page-range></nlm-citation>
</ref>
<ref id="B55">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Peripheral lymphocyte subset and serum cytokine profiles of patients with West syndrome]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shiihara]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Miyashita]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Yoshizumi]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Watanabe]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Yamada]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Kato]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Brain Dev]]></source>
<year>2010</year>
<volume>32</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>695-702</page-range></nlm-citation>
</ref>
<ref id="B56">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Changes of regulatory T cells in the peripheral blood of children with epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Ma]]></surname>
<given-names><![CDATA[W.N.]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<source><![CDATA[Zhongguo Dang Dai ErKeZaZhi]]></source>
<year>2011</year>
<volume>13</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>889-92</page-range></nlm-citation>
</ref>
<ref id="B57">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stêpieñ]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Tomaszewski]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Tomaszewska]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Czuczwar]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Pharmacological Reports]]></source>
<year>2012</year>
<volume>64</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1011-9</page-range></nlm-citation>
</ref>
<ref id="B58">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Anticonvulsive effect of atorvastatin on pentylenetetrazole-induced seizures in mice: the role of nitric oxide pathway]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moazzami]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Emamzadeh-Fard]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Shabani]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Fundam. Clin. Pharmacol.]]></source>
<year>2013</year>
<volume>27</volume>
<page-range>387-92</page-range></nlm-citation>
</ref>
<ref id="B59">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Effects of two different cycles of vagus nerve stimulation on interictal epileptiform discharges]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santiago-Rodríguez]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso-Vanegas]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Cárdenas-Morales]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Harmony]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Bernardino]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Bouzas]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Seizure J. Br. Epilepsy Assoc.]]></source>
<year>2006</year>
<volume>15</volume>
<page-range>615-20</page-range></nlm-citation>
</ref>
<ref id="B60">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Animal models for vagus nerve stimulation in epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aalbers]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Vles]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Klinkenberg]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Hoogland]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Majoie]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Rijkers]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<source><![CDATA[Exp. Neurol.]]></source>
<year>2011</year>
<volume>230</volume>
<page-range>167-75</page-range></nlm-citation>
</ref>
<ref id="B61">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Vagus nerve stimulation inhibits seizure activity and protects blood-brain barrier integrity in kindled rats with cortical dysplasia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaya]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Life Sci.]]></source>
<year>2013</year>
<volume>92</volume>
<page-range>289-97</page-range></nlm-citation>
</ref>
<ref id="B62">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Borovikova]]></surname>
<given-names><![CDATA[L.V.]]></given-names>
</name>
</person-group>
<source><![CDATA[Nature]]></source>
<year>2000</year>
<volume>405</volume>
<page-range>458-62</page-range></nlm-citation>
</ref>
<ref id="B63">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Electrical Vagus Nerve Stimulation Attenuates Systemic Inflammation and Improves Survival in a Rat Heatstroke Model]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yamakawa]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<source><![CDATA[PLoS One]]></source>
<year>2013</year>
<volume>8</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>e56728</page-range></nlm-citation>
</ref>
<ref id="B64">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The selective cyclooxygenase 2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kunz]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Oliw]]></surname>
<given-names><![CDATA[E.H.]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur. J. Neurosci.]]></source>
<year>2001</year>
<volume>13</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>569-75</page-range></nlm-citation>
</ref>
<ref id="B65">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Lipopolysaccharide induced increase in seizure activity in two animal models of absence epilepsy WAG/Rijand GAERS rats and Long Evans rats]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kovács]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Dobolyi]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Juhász]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Kékesi]]></surname>
<given-names><![CDATA[K.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Brain Res. Bull.]]></source>
<year>2014</year>
<volume>104</volume>
<page-range>7-18</page-range></nlm-citation>
</ref>
<ref id="B66">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[M.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Quan]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Gueorguieva]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Ganesh]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Dingledine]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neurobiol. Dis.]]></source>
<year>2015</year>
<volume>76</volume>
<page-range>126-36</page-range></nlm-citation>
</ref>
<ref id="B67">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Antiepileptogenic effects of the selective COX-2 inhibitor etoricoxib, on the development of spontaneous absence seizures in WAG/Rij rats]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Citraro]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Leo]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Marra]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[De Sarro]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Russo]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Brain Res. Bull.]]></source>
<year>2015</year>
<volume>113</volume>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B68">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Effect pf cyclooxygenase (COX-2) inhibitors in various animal models (bicullone, picrotoxin, maximal electroschock convulsions) of epilepsy with possible mechanism of action]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dhir]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Naidu]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Kulkarni]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Indian J. Exp. Biol.]]></source>
<year></year>
<volume>44</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>286-91</page-range></nlm-citation>
</ref>
<ref id="B69">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Minocycline inhibits brain inflammation and attenuates spontaneous recurrent seizures following pilocarpine-induced status epilepticus]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuroscience]]></source>
<year>2015</year>
<volume>287</volume>
<page-range>144-56</page-range></nlm-citation>
</ref>
<ref id="B70">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Lovastatin decreases the synthesis of inflammatory mediators during epileptoge-nesis in the hippocampus ofrats submitted to pilocarpine-induced epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gouveia]]></surname>
<given-names><![CDATA[T.L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsy Behav.]]></source>
<year>2014</year>
<volume>36</volume>
<page-range>68-73</page-range></nlm-citation>
</ref>
<ref id="B71">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Immunomodulatory treatments in epilepsy. Semin]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Melvin]]></surname>
<given-names><![CDATA[J.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Huntley Hardison]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<source><![CDATA[Pediatr. Neurol.]]></source>
<year>2014</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>232-7</page-range></nlm-citation>
</ref>
<ref id="B72">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Immuno- and antiinflammatory therapies in epileptic disorders]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Özkara]]></surname>
<given-names><![CDATA[Ç.]]></given-names>
</name>
<name>
<surname><![CDATA[Vigevano]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsia.]]></source>
<year>2011</year>
<volume>52</volume>
<numero>^s3</numero>
<issue>^s3</issue>
<supplement>3</supplement>
<page-range>45-51</page-range></nlm-citation>
</ref>
<ref id="B73">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Treatment of refractory epilepsy with intravenous immunoglobulins. Results of the first double-blind/dosefinding clinical study]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Rijckevorsel-Harmant]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Delire]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Schmitz-Moorman]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Wieser]]></surname>
<given-names><![CDATA[H.G.]]></given-names>
</name>
</person-group>
<source><![CDATA[Int. J. Clin. Lab. Res.]]></source>
<year>1994</year>
<volume>24</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>162-6</page-range></nlm-citation>
</ref>
<ref id="B74">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[A comparative study of hydrocortisone versus deflazacort in drug-resistant epilepsy of childhood]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grosso]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Farnetani]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Mostardini]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Cordelli]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Berardi]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Balestri]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsy Res.]]></source>
<year>2008</year>
<volume>81</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>80-5</page-range></nlm-citation>
</ref>
<ref id="B75">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Corticosteroids as treatment of epileptic syndromes with continuous spike-waves during slow-wave sleep]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buzatu]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Bulteau]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Altuzarra]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Dulac]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
<name>
<surname><![CDATA[Van Bogaert]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsia]]></source>
<year>2009</year>
<volume>50</volume>
<numero>^s7</numero>
<issue>^s7</issue>
<supplement>7</supplement>
<page-range>68-72</page-range></nlm-citation>
</ref>
<ref id="B76">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Intravenous immunoglobulin therapy in intractable childhood epilepsy: open-label study and review of the literature]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mikati]]></surname>
<given-names><![CDATA[M.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Kurdi]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[El-Khoury]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Rahi]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Raad]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsy Behav.]]></source>
<year>2010</year>
<volume>17</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>90-4</page-range></nlm-citation>
</ref>
<ref id="B77">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Novel Frontiers in Epilepsy Treatments: Preventing Epileptogenesis by Targeting Inflammation]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[D&#8217;Ambrosio]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Eastman]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Fattore]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Perucca]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Expert. Rev. Neurother]]></source>
<year>2013</year>
<volume>13</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>615-25</page-range></nlm-citation>
</ref>
<ref id="B78">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Treatment of infantile spasms]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hancock]]></surname>
<given-names><![CDATA[E.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Osborne]]></surname>
<given-names><![CDATA[J.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Edwards]]></surname>
<given-names><![CDATA[S.W.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cochrane Database Syst. Rev.]]></source>
<year>2013</year>
<volume>5</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>CD001770</page-range></nlm-citation>
</ref>
<ref id="B79">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Inmunoterapia para la epilepsia farmacoresistente]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rüegg]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Panzer]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neurology]]></source>
<year>2014</year>
<volume>82</volume>
<page-range>1572-3</page-range></nlm-citation>
</ref>
<ref id="B80">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cyclooxygenase-2 in epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsia]]></source>
<year>2013</year>
<volume>55</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>17-25</page-range></nlm-citation>
</ref>
<ref id="B81">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The search for circulating epilepsy biomarkers]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hegde]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Lowenstein]]></surname>
<given-names><![CDATA[D.H.]]></given-names>
</name>
</person-group>
<source><![CDATA[Biomark Med.]]></source>
<year>2014</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>413-27</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
